Date:April 27, 2026

The AORTIC–Bio Usawa Microgrant Program was launched to support African researchers addressing serious gaps in cancer care systems. Out of more than 150 applications, five were selected for this inaugural cohort.
From Zambia, Martha Mwaba is asking an important question about where care happens and where it should.
Her project explores the clinical outcomes of Zambian cancer patients referred abroad for radiotherapy and chemo-radiotherapy, and what this means for strengthening domestic cancer care capacity.
As many countries continue to rely on external treatment pathways, this research will provide insight into how local systems can be strengthened for long-term sustainability.
The inaugural AORTIC–Bio Usawa Microgrant Program brings together a cohort of early- and mid-career researchers, each addressing critical gaps in cancer…
April 2026The AORTIC—Bio Usawa Microgrant Program is supporting a cohort of five early-career researchers advancing practical solutions in cancer care. The group …
April 2026Over the next few days, we will spotlight the inaugural cohort of the AORTIC—Bio Usawa Microgrant Program for early- and mid-career cancer researchers. …
April 2026